Exosomes as the source of biomarkers of metabolic diseases

Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diab...

Full description

Saved in:
Bibliographic Details
Published inAnnals of pediatric endocrinology & metabolism Vol. 21; no. 3; pp. 119 - 125
Main Authors Lee, Min-Jae, Park, Dong-Ho, Kang, Ju-Hee
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Pediatric Endocrinology 01.09.2016
Korean Society of Pediatric Endocrinology
대한소아내분비학회
Subjects
Online AccessGet full text
ISSN2287-1012
2287-1292
DOI10.6065/apem.2016.21.3.119

Cover

Abstract Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
AbstractList Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism. KCI Citation Count: 0
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro , in vivo and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies support the hypothesis that exosomes released from various cell types play roles in the progression of metabolic disorders including type 2 diabetes. Based on this concept and advances in other diseases, the proteins, mRNA, microRNA and lipids in exosomes isolated from biological fluids have been proposed as biomarkers in metabolic disorders. However, several problems with the development of clinically applicable biomarkers have not been resolved. In this review, the biologic functions of exosomes are briefly introduced, and we discuss the technical and practical pros and cons of different methods of exosome isolation for the identification of exosomal biomarkers of metabolic disorders. Standardization of preanalytical variables and isolation of high-purity exosomes from fully characterized biological fluids will be necessary for the identification of useful exosomal biomarkers that can provide insights into the pathogenic mechanisms of complications of metabolic syndrome and of whole-body metabolism.
Author Park, Dong-Ho
Lee, Min-Jae
Kang, Ju-Hee
AuthorAffiliation 1 Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea
2 Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea
3 Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea
AuthorAffiliation_xml – name: 1 Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea
– name: 3 Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea
– name: 2 Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea
Author_xml – sequence: 1
  givenname: Min-Jae
  surname: Lee
  fullname: Lee, Min-Jae
  organization: Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea., Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea
– sequence: 2
  givenname: Dong-Ho
  surname: Park
  fullname: Park, Dong-Ho
  organization: Department of Kinesiology, College of Arts and Sports, Inha University School of Medicine, Incheon, Korea
– sequence: 3
  givenname: Ju-Hee
  surname: Kang
  fullname: Kang, Ju-Hee
  organization: Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Incheon, Korea., Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27777903$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002152674$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kk1v1DAQhi1URD_oH-CAcoTDBo-dxDYHpKpqYaVKSKicLdsZt-4m8WJnK_j3eHe7iHLAl_HH-z5jj-eUHE1xQkLeAK072rUfzBrHmlHoagY1rwHUC3LCmBQLYIodHeYU2DE5z_mBliEo67h8RY6ZKENRfkI-Xv2MOY6YK5Or-R6rHDfJYRV9ZUMcTVphytvViLOxcQiu6kNGkzG_Ji-9GTKeP8Uz8v366vbyy-Lm6-fl5cXNwrUtVwvjhZcKfd96RNsLkJwzR5nwvmkakH2D4JS0IGSDqu-6ngKnjeKMFlvn-Rl5v-dOyeuVCzqasIt3Ua-Svvh2u9QAwBjwol3utX00D3qdQnnBr51htxHTnTZpDm5A3XppmWl8wy1tmGwl9p0w0jhnJVJrC-vTnrXe2BF7h9OczPAM-vxkCvflTo-6pYJDKwrg3RMgxR8bzLMeQ3Y4DGbCuMm6VKJUqKVKFunbv3P9SXL4qCKQe4FLMeeEXrswmznEbeowaKB62xZ62xZ62xaagealLqpY2T_WA_0_pt-eDbrf
CitedBy_id crossref_primary_10_1080_02713683_2020_1797107
crossref_primary_10_1111_aji_12788
crossref_primary_10_1080_20013078_2018_1473707
crossref_primary_10_1007_s12015_022_10342_y
crossref_primary_10_1007_s00210_024_03762_9
crossref_primary_10_1016_j_ncrna_2020_03_001
crossref_primary_10_2147_NSS_S310351
crossref_primary_10_1007_s40291_020_00493_4
crossref_primary_10_1016_j_lfs_2019_116861
crossref_primary_10_1021_acssensors_3c00689
crossref_primary_10_1039_D1NA00330E
crossref_primary_10_1038_s41598_019_50244_7
crossref_primary_10_1088_1361_6528_abba58
crossref_primary_10_1096_fj_201700417R
crossref_primary_10_1128_mSphere_00030_18
crossref_primary_10_35118_apjmbb_2020_028_1_03
crossref_primary_10_1016_j_theriogenology_2018_03_024
crossref_primary_10_3233_CBM_170727
crossref_primary_10_18632_oncotarget_24809
crossref_primary_10_1007_s12265_020_09966_7
crossref_primary_10_3390_ijms19113383
crossref_primary_10_1080_10408363_2022_2027864
crossref_primary_10_1210_endocr_bqab032
crossref_primary_10_1093_molehr_gay019
crossref_primary_10_1038_s41598_017_05541_4
crossref_primary_10_1007_s40200_019_00404_3
crossref_primary_10_1016_j_metabol_2021_154727
crossref_primary_10_1080_15384101_2019_1638694
crossref_primary_10_1007_s00441_023_03802_5
crossref_primary_10_1080_14789450_2017_1364629
crossref_primary_10_18502_wkmj_v66i4_17768
crossref_primary_10_3390_ijms18030456
crossref_primary_10_1007_s10529_023_03430_7
crossref_primary_10_1038_s41598_020_75561_0
crossref_primary_10_3389_fbioe_2022_1019821
crossref_primary_10_3390_cancers14122826
crossref_primary_10_1016_j_trsl_2018_01_005
Cites_doi 10.1038/nrendo.2016.76
10.1016/j.jss.2014.06.050
10.1038/srep21447
10.4049/jimmunol.1103466
10.1002/bies.201100169
10.1038/nrd3978
10.1016/j.tem.2016.03.012
10.1371/journal.pone.0027809
10.3402/jev.v3.24858
10.1021/pr8004887
10.1016/j.yexcr.2010.04.006
10.1016/j.jprot.2013.10.037
10.1111/j.1751-7176.2012.00631.x
10.1210/en.2006-1479
10.1093/eurheartj/ehq167
10.1016/j.atherosclerosis.2009.06.037
10.1007/s00125-016-3882-y
10.2337/db09-0216
10.1562/0031-8655(2003)078<0241:CACACB>2.0.CO;2
10.1161/01.CIR.0000036596.59665.C6
10.1186/1475-2840-13-37
10.1038/ncb1132
10.1038/ncb2502
10.3402/jev.v3.26913
10.1016/j.jalz.2014.06.008
10.1177/1479164111434318
10.1038/nature07961
10.1093/eurheartj/ehu153
10.1007/s00125-014-3337-2
10.1016/j.addr.2010.06.001
10.1016/j.scr.2011.01.001
10.1681/ASN.2013070763
10.1111/j.1600-0854.2007.00566.x
10.1007/s12265-011-9296-9
10.3402/jev.v5.29289
10.1016/j.semcancer.2014.04.009
10.1093/aje/kwh281
10.1007/s00401-014-1314-y
10.1530/JOE-15-0201
10.1523/JNEUROSCI.5699-09.2010
10.3402/jev.v2i0.20360
10.1007/s10930-015-9616-z
10.4049/jimmunol.180.2.817
10.3402/jev.v4.27031
10.2353/ajpath.2008.080228
10.1371/journal.pone.0037036
10.1210/jc.2013-3843
10.1161/CIRCULATIONAHA.113.001720
10.1016/j.yjmcc.2014.05.001
10.1371/journal.pone.0003377
10.1002/pmic.201300282
10.3389/fphys.2012.00145
10.2217/rme.11.35
10.3402/jev.v4.29509
10.3389/fphys.2012.00124
10.1038/ijo.2011.115
10.1067/mcp.2001.113989
ContentType Journal Article
Copyright 2016 Annals of Pediatric Endocrinology & Metabolism
Copyright_xml – notice: 2016 Annals of Pediatric Endocrinology & Metabolism
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.6065/apem.2016.21.3.119
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2287-1292
EndPage 125
ExternalDocumentID oai_kci_go_kr_ARTI_1112213
oai_doaj_org_article_5f8b2a4f43b042858ed67a8accb8e0bb
PMC5073157
27777903
10_6065_apem_2016_21_3_119
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
GroupedDBID 5-W
8JR
8XY
AAYXX
ABDBF
ACUHS
ADBBV
ADRAZ
AEGXH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EF.
GROUPED_DOAJ
GX1
HYE
IPNFZ
KQ8
M48
OK1
PGMZT
RIG
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c5539-af7f89efd5feebd718332c027ff44418d4e1c98b1784e9d66d01304932089e6f3
IEDL.DBID M48
ISSN 2287-1012
IngestDate Tue Nov 21 21:39:42 EST 2023
Wed Aug 27 01:24:10 EDT 2025
Thu Aug 21 18:40:14 EDT 2025
Fri Jul 11 06:22:26 EDT 2025
Thu Jan 02 22:21:17 EST 2025
Tue Jul 01 03:45:54 EDT 2025
Thu Apr 24 23:01:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Biomarkers
Metabolic syndrome X
Exosomes
Diabetes mellitus
Standardization
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5539-af7f89efd5feebd718332c027ff44418d4e1c98b1784e9d66d01304932089e6f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
G704-002175.2016.21.3.010
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.6065/apem.2016.21.3.119
PMID 27777903
PQID 1835535098
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1112213
doaj_primary_oai_doaj_org_article_5f8b2a4f43b042858ed67a8accb8e0bb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5073157
proquest_miscellaneous_1835535098
pubmed_primary_27777903
crossref_citationtrail_10_6065_apem_2016_21_3_119
crossref_primary_10_6065_apem_2016_21_3_119
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-09-01
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 09
  year: 2016
  text: 2016-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Annals of pediatric endocrinology & metabolism
PublicationTitleAlternate Ann Pediatr Endocrinol Metab
PublicationYear 2016
Publisher The Korean Society of Pediatric Endocrinology
Korean Society of Pediatric Endocrinology
대한소아내분비학회
Publisher_xml – name: The Korean Society of Pediatric Endocrinology
– name: Korean Society of Pediatric Endocrinology
– name: 대한소아내분비학회
References Quesenberry (10.6065/apem.2016.21.3.119_ref11) 2010; 62
Santovito (10.6065/apem.2016.21.3.119_ref29) 2014; 99
Livshits (10.6065/apem.2016.21.3.119_ref39) 2016; 6
Diamant (10.6065/apem.2016.21.3.119_ref21) 2002; 106
Emmanouilidou (10.6065/apem.2016.21.3.119_ref18) 2010; 30
Shi (10.6065/apem.2016.21.3.119_ref48) 2014; 128
Feng (10.6065/apem.2016.21.3.119_ref23) 2010; 208
Wang (10.6065/apem.2016.21.3.119_ref32) 2014; 74
Koeck (10.6065/apem.2016.21.3.119_ref36) 2014; 192
Kim (10.6065/apem.2016.21.3.119_ref24) 2012; 7
Hong (10.6065/apem.2016.21.3.119_ref46) 2016; 5
Deng (10.6065/apem.2016.21.3.119_ref30) 2009; 58
O'Neill (10.6065/apem.2016.21.3.119_ref33) 2016; 27
Lee (10.6065/apem.2016.21.3.119_ref28) 2015; 34
Cai (10.6065/apem.2016.21.3.119_ref16) 2012; 188
Chivet (10.6065/apem.2016.21.3.119_ref9) 2012; 3
Van Deun (10.6065/apem.2016.21.3.119_ref44) 2014; 3
Conde-Vancells (10.6065/apem.2016.21.3.119_ref3) 2008; 7
Lobb (10.6065/apem.2016.21.3.119_ref49) 2015; 4
Kanhai (10.6065/apem.2016.21.3.119_ref38) 2012; 36
Lai (10.6065/apem.2016.21.3.119_ref12) 2011; 6
Sun (10.6065/apem.2016.21.3.119_ref56) 2012; 9
EL Andaloussi (10.6065/apem.2016.21.3.119_ref7) 2013; 12
Cocucci (10.6065/apem.2016.21.3.119_ref40) 2007; 8
Guescini (10.6065/apem.2016.21.3.119_ref1) 2010; 316
Aoki (10.6065/apem.2016.21.3.119_ref2) 2007; 148
Zubiri (10.6065/apem.2016.21.3.119_ref57) 2014; 96
Jang (10.6065/apem.2016.21.3.119_ref10) 2004; 6
Lawson (10.6065/apem.2016.21.3.119_ref35) 2016; 228
Camussi (10.6065/apem.2016.21.3.119_ref14) 2011; 1
Simhadri (10.6065/apem.2016.21.3.119_ref8) 2008; 3
Linares (10.6065/apem.2016.21.3.119_ref43) 2015; 4
Witwer (10.6065/apem.2016.21.3.119_ref58) 2013; 2
Timmers (10.6065/apem.2016.21.3.119_ref13) 2011; 6
Jalabert (10.6065/apem.2016.21.3.119_ref27) 2016; 59
Rak (10.6065/apem.2016.21.3.119_ref15) 2012; 34
Jayachandran (10.6065/apem.2016.21.3.119_ref20) 2011; 4
Kranendonk (10.6065/apem.2016.21.3.119_ref54) 2014; 13
Agouni (10.6065/apem.2016.21.3.119_ref51) 2008; 173
Jansen (10.6065/apem.2016.21.3.119_ref31) 2013; 128
Ogata (10.6065/apem.2016.21.3.119_ref25) 2003; 78
Amabile (10.6065/apem.2016.21.3.119_ref52) 2014; 35
Kalra (10.6065/apem.2016.21.3.119_ref45) 2013; 13
Bellingham (10.6065/apem.2016.21.3.119_ref17) 2012; 3
Nicklas (10.6065/apem.2016.21.3.119_ref37) 2004; 160
Eken (10.6065/apem.2016.21.3.119_ref41) 2008; 180
Fiandaca (10.6065/apem.2016.21.3.119_ref47) 2015; 11
Villarroya-Beltri (10.6065/apem.2016.21.3.119_ref6) 2014; 28
Agouni (10.6065/apem.2016.21.3.119_ref50) 2011; 6
Raiborg (10.6065/apem.2016.21.3.119_ref4) 2009; 458
Baietti (10.6065/apem.2016.21.3.119_ref5) 2012; 14
Biomarkers Definitions Working Group (10.6065/apem.2016.21.3.119_ref34) 2001; 69
Safdar (10.6065/apem.2016.21.3.119_ref26) 2016; 12
Burger (10.6065/apem.2016.21.3.119_ref55) 2014; 25
Aswad (10.6065/apem.2016.21.3.119_ref19) 2014; 57
D'Alessandra (10.6065/apem.2016.21.3.119_ref22) 2010; 31
Lötvall (10.6065/apem.2016.21.3.119_ref42) 2014; 3
Chen (10.6065/apem.2016.21.3.119_ref53) 2012; 14
19675137 - Diabetes. 2009 Nov;58(11):2498-505
22442051 - Bioessays. 2012 Jun;34(6):489-97
26194179 - J Extracell Vesicles. 2015 Jul 17;4:27031
25317274 - J Extracell Vesicles. 2014 Sep 18;3:null
20484626 - J Neurosci. 2010 May 19;30(20):6838-51
27230949 - Nat Rev Endocrinol. 2016 Sep;12(9):504-17
15466496 - Am J Epidemiol. 2004 Oct 15;160(8):741-9
12417540 - Circulation. 2002 Nov 5;106(19):2442-7
24997849 - Acta Neuropathol. 2014 Nov;128(5):639-50
24676640 - J Am Soc Nephrol. 2014 Jul;25(7):1401-7
21786187 - J Cardiovasc Transl Res. 2011 Dec;4(6):811-22
22660413 - Nat Cell Biol. 2012 Jun 03;14(7):677-85
21969178 - Am J Cancer Res. 2011;1(1):98-110
24211404 - J Proteomics. 2014 Jan 16;96:92-102
17478559 - Endocrinology. 2007 Aug;148(8):3850-62
22563321 - Front Physiol. 2012 May 03;3:124
19674745 - Atherosclerosis. 2010 Jan;208(1):264-9
24009894 - J Extracell Vesicles. 2013 May 27;2:null
22747618 - J Clin Hypertens (Greenwich). 2012 Jul;14(7):455-60
23584393 - Nat Rev Drug Discov. 2013 May;12(5):347-57
21419744 - Stem Cell Res. 2011 May;6(3):206-14
25130657 - Alzheimers Dement. 2015 Jun;11(6):600-7.e1
14556310 - Photochem Photobiol. 2003 Sep;78(3):241-7
26743452 - J Endocrinol. 2016 Feb;228(2):R57-71
24937531 - J Clin Endocrinol Metab. 2014 Sep;99(9):E1681-5
22654762 - Front Physiol. 2012 May 28;3:145
20558219 - Adv Drug Deliv Rev. 2010 Sep 30;62(12):1141-8
19367702 - J Proteome Res. 2008 Dec;7(12):5157-66
24742886 - Eur Heart J. 2014 Nov 7;35(42):2972-9
20534597 - Eur Heart J. 2010 Nov;31(22):2765-73
25998041 - Protein J. 2015 Jun;34(3):220-35
25073444 - Diabetologia. 2014 Oct;57(10):2155-64
27018366 - J Extracell Vesicles. 2016 Mar 24;5:29289
24769058 - Semin Cancer Biol. 2014 Oct;28:3-13
18852879 - PLoS One. 2008;3(10):e3377
27022711 - Sci Rep. 2016 Mar 29;6:21447
27150849 - Trends Endocrinol Metab. 2016 Jun;27(6):363-74
26700615 - J Extracell Vesicles. 2015 Dec 23;4:29509
17488290 - Traffic. 2007 Jun;8(6):742-57
15133469 - Nat Cell Biol. 2004 Jun;6(6):532-9
25086727 - J Surg Res. 2014 Dec;192(2):268-75
24825548 - J Mol Cell Cardiol. 2014 Sep;74:139-50
11240971 - Clin Pharmacol Ther. 2001 Mar;69(3):89-95
21749206 - Regen Med. 2011 Jul;6(4):481-92
22573809 - J Immunol. 2012 Jun 15;188(12):5954-61
19325624 - Nature. 2009 Mar 26;458(7237):445-52
22110764 - PLoS One. 2011;6(11):e27809
26852333 - Diabetologia. 2016 May;59(5):1049-58
24498934 - Cardiovasc Diabetol. 2014 Feb 05;13:37
20399774 - Exp Cell Res. 2010 Jul 15;316(12):1977-84
18178820 - J Immunol. 2008 Jan 15;180(2):817-24
25536934 - J Extracell Vesicles. 2014 Dec 22;3:26913
24014835 - Circulation. 2013 Oct 29;128(18):2026-38
24115447 - Proteomics. 2013 Nov;13(22):3354-64
18772329 - Am J Pathol. 2008 Oct;173(4):1210-9
21712810 - Int J Obes (Lond). 2012 May;36(5):695-702
22388283 - Diab Vasc Dis Res. 2012 Oct;9(4):301-8
22615882 - PLoS One. 2012;7(5):e37036
References_xml – volume: 12
  start-page: 504
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref26
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2016.76
– volume: 192
  start-page: 268
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref36
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2014.06.050
– volume: 6
  start-page: 21447
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref39
  publication-title: Sci Rep
  doi: 10.1038/srep21447
– volume: 188
  start-page: 5954
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref16
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1103466
– volume: 34
  start-page: 489
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref15
  publication-title: Bioessays
  doi: 10.1002/bies.201100169
– volume: 12
  start-page: 347
  year: 2013
  ident: 10.6065/apem.2016.21.3.119_ref7
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3978
– volume: 27
  start-page: 363
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref33
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2016.03.012
– volume: 6
  start-page: e27809
  year: 2011
  ident: 10.6065/apem.2016.21.3.119_ref50
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0027809
– volume: 3
  start-page: 24858
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref44
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v3.24858
– volume: 7
  start-page: 5157
  year: 2008
  ident: 10.6065/apem.2016.21.3.119_ref3
  publication-title: J Proteome Res
  doi: 10.1021/pr8004887
– volume: 316
  start-page: 1977
  year: 2010
  ident: 10.6065/apem.2016.21.3.119_ref1
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2010.04.006
– volume: 96
  start-page: 92
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref57
  publication-title: J Proteomics
  doi: 10.1016/j.jprot.2013.10.037
– volume: 14
  start-page: 455
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref53
  publication-title: J Clin Hypertens (Greenwich)
  doi: 10.1111/j.1751-7176.2012.00631.x
– volume: 148
  start-page: 3850
  year: 2007
  ident: 10.6065/apem.2016.21.3.119_ref2
  publication-title: Endocrinology
  doi: 10.1210/en.2006-1479
– volume: 31
  start-page: 2765
  year: 2010
  ident: 10.6065/apem.2016.21.3.119_ref22
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehq167
– volume: 208
  start-page: 264
  year: 2010
  ident: 10.6065/apem.2016.21.3.119_ref23
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2009.06.037
– volume: 59
  start-page: 1049
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref27
  publication-title: Diabetologia
  doi: 10.1007/s00125-016-3882-y
– volume: 58
  start-page: 2498
  year: 2009
  ident: 10.6065/apem.2016.21.3.119_ref30
  publication-title: Diabetes
  doi: 10.2337/db09-0216
– volume: 78
  start-page: 241
  year: 2003
  ident: 10.6065/apem.2016.21.3.119_ref25
  publication-title: Photochem Photobiol
  doi: 10.1562/0031-8655(2003)078<0241:CACACB>2.0.CO;2
– volume: 106
  start-page: 2442
  year: 2002
  ident: 10.6065/apem.2016.21.3.119_ref21
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000036596.59665.C6
– volume: 13
  start-page: 37
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref54
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/1475-2840-13-37
– volume: 6
  start-page: 532
  year: 2004
  ident: 10.6065/apem.2016.21.3.119_ref10
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1132
– volume: 14
  start-page: 677
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref5
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2502
– volume: 3
  start-page: 26913
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref42
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v3.26913
– volume: 11
  start-page: 600
  year: 2015
  ident: 10.6065/apem.2016.21.3.119_ref47
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2014.06.008
– volume: 9
  start-page: 301
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref56
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164111434318
– volume: 1
  start-page: 98
  year: 2011
  ident: 10.6065/apem.2016.21.3.119_ref14
  publication-title: Am J Cancer Res
– volume: 458
  start-page: 445
  year: 2009
  ident: 10.6065/apem.2016.21.3.119_ref4
  publication-title: Nature
  doi: 10.1038/nature07961
– volume: 35
  start-page: 2972
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref52
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehu153
– volume: 57
  start-page: 2155
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref19
  publication-title: Diabetologia
  doi: 10.1007/s00125-014-3337-2
– volume: 62
  start-page: 1141
  year: 2010
  ident: 10.6065/apem.2016.21.3.119_ref11
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2010.06.001
– volume: 6
  start-page: 206
  year: 2011
  ident: 10.6065/apem.2016.21.3.119_ref13
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2011.01.001
– volume: 25
  start-page: 1401
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref55
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013070763
– volume: 8
  start-page: 742
  year: 2007
  ident: 10.6065/apem.2016.21.3.119_ref40
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2007.00566.x
– volume: 4
  start-page: 811
  year: 2011
  ident: 10.6065/apem.2016.21.3.119_ref20
  publication-title: J Cardiovasc Transl Res
  doi: 10.1007/s12265-011-9296-9
– volume: 5
  start-page: 29289
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref46
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v5.29289
– volume: 28
  start-page: 3
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref6
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2014.04.009
– volume: 160
  start-page: 741
  year: 2004
  ident: 10.6065/apem.2016.21.3.119_ref37
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwh281
– volume: 128
  start-page: 639
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref48
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-014-1314-y
– volume: 228
  start-page: R57
  year: 2016
  ident: 10.6065/apem.2016.21.3.119_ref35
  publication-title: J Endocrinol
  doi: 10.1530/JOE-15-0201
– volume: 30
  start-page: 6838
  year: 2010
  ident: 10.6065/apem.2016.21.3.119_ref18
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5699-09.2010
– volume: 2
  start-page: 20360
  year: 2013
  ident: 10.6065/apem.2016.21.3.119_ref58
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v2i0.20360
– volume: 34
  start-page: 220
  year: 2015
  ident: 10.6065/apem.2016.21.3.119_ref28
  publication-title: Protein J
  doi: 10.1007/s10930-015-9616-z
– volume: 180
  start-page: 817
  year: 2008
  ident: 10.6065/apem.2016.21.3.119_ref41
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.2.817
– volume: 4
  start-page: 27031
  year: 2015
  ident: 10.6065/apem.2016.21.3.119_ref49
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.27031
– volume: 173
  start-page: 1210
  year: 2008
  ident: 10.6065/apem.2016.21.3.119_ref51
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2008.080228
– volume: 7
  start-page: e37036
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref24
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0037036
– volume: 99
  start-page: E1681
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref29
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-3843
– volume: 128
  start-page: 2026
  year: 2013
  ident: 10.6065/apem.2016.21.3.119_ref31
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.001720
– volume: 74
  start-page: 139
  year: 2014
  ident: 10.6065/apem.2016.21.3.119_ref32
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2014.05.001
– volume: 3
  start-page: e3377
  year: 2008
  ident: 10.6065/apem.2016.21.3.119_ref8
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0003377
– volume: 13
  start-page: 3354
  year: 2013
  ident: 10.6065/apem.2016.21.3.119_ref45
  publication-title: Proteomics
  doi: 10.1002/pmic.201300282
– volume: 3
  start-page: 145
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref9
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00145
– volume: 6
  start-page: 481
  year: 2011
  ident: 10.6065/apem.2016.21.3.119_ref12
  publication-title: Regen Med
  doi: 10.2217/rme.11.35
– volume: 4
  start-page: 29509
  year: 2015
  ident: 10.6065/apem.2016.21.3.119_ref43
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.29509
– volume: 3
  start-page: 124
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref17
  publication-title: Front Physiol
  doi: 10.3389/fphys.2012.00124
– volume: 36
  start-page: 695
  year: 2012
  ident: 10.6065/apem.2016.21.3.119_ref38
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2011.115
– volume: 69
  start-page: 89
  year: 2001
  ident: 10.6065/apem.2016.21.3.119_ref34
  publication-title: Clin Pharmacol Ther
  doi: 10.1067/mcp.2001.113989
– reference: 18852879 - PLoS One. 2008;3(10):e3377
– reference: 19675137 - Diabetes. 2009 Nov;58(11):2498-505
– reference: 24211404 - J Proteomics. 2014 Jan 16;96:92-102
– reference: 19674745 - Atherosclerosis. 2010 Jan;208(1):264-9
– reference: 11240971 - Clin Pharmacol Ther. 2001 Mar;69(3):89-95
– reference: 20399774 - Exp Cell Res. 2010 Jul 15;316(12):1977-84
– reference: 22660413 - Nat Cell Biol. 2012 Jun 03;14(7):677-85
– reference: 18772329 - Am J Pathol. 2008 Oct;173(4):1210-9
– reference: 26743452 - J Endocrinol. 2016 Feb;228(2):R57-71
– reference: 24769058 - Semin Cancer Biol. 2014 Oct;28:3-13
– reference: 19367702 - J Proteome Res. 2008 Dec;7(12):5157-66
– reference: 15466496 - Am J Epidemiol. 2004 Oct 15;160(8):741-9
– reference: 25998041 - Protein J. 2015 Jun;34(3):220-35
– reference: 24014835 - Circulation. 2013 Oct 29;128(18):2026-38
– reference: 20534597 - Eur Heart J. 2010 Nov;31(22):2765-73
– reference: 22388283 - Diab Vasc Dis Res. 2012 Oct;9(4):301-8
– reference: 24937531 - J Clin Endocrinol Metab. 2014 Sep;99(9):E1681-5
– reference: 18178820 - J Immunol. 2008 Jan 15;180(2):817-24
– reference: 22654762 - Front Physiol. 2012 May 28;3:145
– reference: 25317274 - J Extracell Vesicles. 2014 Sep 18;3:null
– reference: 22747618 - J Clin Hypertens (Greenwich). 2012 Jul;14(7):455-60
– reference: 24676640 - J Am Soc Nephrol. 2014 Jul;25(7):1401-7
– reference: 25073444 - Diabetologia. 2014 Oct;57(10):2155-64
– reference: 22563321 - Front Physiol. 2012 May 03;3:124
– reference: 20558219 - Adv Drug Deliv Rev. 2010 Sep 30;62(12):1141-8
– reference: 24825548 - J Mol Cell Cardiol. 2014 Sep;74:139-50
– reference: 24115447 - Proteomics. 2013 Nov;13(22):3354-64
– reference: 24498934 - Cardiovasc Diabetol. 2014 Feb 05;13:37
– reference: 27150849 - Trends Endocrinol Metab. 2016 Jun;27(6):363-74
– reference: 15133469 - Nat Cell Biol. 2004 Jun;6(6):532-9
– reference: 22442051 - Bioessays. 2012 Jun;34(6):489-97
– reference: 22615882 - PLoS One. 2012;7(5):e37036
– reference: 26700615 - J Extracell Vesicles. 2015 Dec 23;4:29509
– reference: 17478559 - Endocrinology. 2007 Aug;148(8):3850-62
– reference: 14556310 - Photochem Photobiol. 2003 Sep;78(3):241-7
– reference: 27022711 - Sci Rep. 2016 Mar 29;6:21447
– reference: 12417540 - Circulation. 2002 Nov 5;106(19):2442-7
– reference: 21749206 - Regen Med. 2011 Jul;6(4):481-92
– reference: 27018366 - J Extracell Vesicles. 2016 Mar 24;5:29289
– reference: 23584393 - Nat Rev Drug Discov. 2013 May;12(5):347-57
– reference: 22110764 - PLoS One. 2011;6(11):e27809
– reference: 22573809 - J Immunol. 2012 Jun 15;188(12):5954-61
– reference: 25086727 - J Surg Res. 2014 Dec;192(2):268-75
– reference: 25536934 - J Extracell Vesicles. 2014 Dec 22;3:26913
– reference: 21419744 - Stem Cell Res. 2011 May;6(3):206-14
– reference: 20484626 - J Neurosci. 2010 May 19;30(20):6838-51
– reference: 21786187 - J Cardiovasc Transl Res. 2011 Dec;4(6):811-22
– reference: 24997849 - Acta Neuropathol. 2014 Nov;128(5):639-50
– reference: 24009894 - J Extracell Vesicles. 2013 May 27;2:null
– reference: 21969178 - Am J Cancer Res. 2011;1(1):98-110
– reference: 25130657 - Alzheimers Dement. 2015 Jun;11(6):600-7.e1
– reference: 17488290 - Traffic. 2007 Jun;8(6):742-57
– reference: 26852333 - Diabetologia. 2016 May;59(5):1049-58
– reference: 26194179 - J Extracell Vesicles. 2015 Jul 17;4:27031
– reference: 21712810 - Int J Obes (Lond). 2012 May;36(5):695-702
– reference: 19325624 - Nature. 2009 Mar 26;458(7237):445-52
– reference: 24742886 - Eur Heart J. 2014 Nov 7;35(42):2972-9
– reference: 27230949 - Nat Rev Endocrinol. 2016 Sep;12(9):504-17
SSID ssj0000702638
Score 2.1948903
SecondaryResourceType review_article
Snippet Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent , and clinical studies...
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro, in vivo and...
Exosomes are extracellular vesicles that contain molecules that regulate the metabolic functions of adjacent or remote cells. Recent in vitro , in vivo and...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 119
SubjectTerms Biomarkers
Diabetes mellitus
Exosomes
Metabolic syndrome X
Review
Standardization
소아과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2AooC4obTxI47dW4taFaRyolJvlh9jWLVNqs1W4uczk6SrXYTgwilKYkf257H9fbFnzNiHBJn8K1PFPYRKcUgV8jhTQYpaJZ2ksOTgfPZVn56rLxfNxcZRX7QnbAoPPAG332QThFdZyUD0vjGQdOuNjzEYqEOg0be29YaYGsfgFrXFeIy1QElQURCryWMG-Xqz72-AnNC53hN8T-KoYbdmpTF4P8413TL_iXf-vn1yYz46ecQezkSyPJwq8Jjdg-4Ju382L5U_ZQfHP_uhv4ah9EOJLK-cftOXfS7J5Z525SwHuruGFRrC1SKW82LN8Iydnxx_-3RazQclVLFppK18brOxkFOTAULC6UZKEVFw5qyQ7pikgEdrAm-NApu0TrReqZC61ZhNZ_mc7XR9By9Z6UHXKpvsUUapBNy3-Gmus8-WA46qBeN3QLk4RxGnwyyuHKoJAtcRuI7AdYI7iQrDFuzjOs_NFEPjr6mPCP91Sop_PT5Aq3CzVbh_WUXB3mPrucu4GPPT9XvvLpcOVcJnUj1CcFmwd3eN67BT0UqJ76C_HRwCiMAilzIFezE19ro8om0pRiPmbrfMYKvA22-6xY8xcDdyb8mb9tX_qOFr9oBgm7a7vWE7q-Ut7CI_WoW3Y1f4BUEbDGQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Exosomes as the source of biomarkers of metabolic diseases
URI https://www.ncbi.nlm.nih.gov/pubmed/27777903
https://www.proquest.com/docview/1835535098
https://pubmed.ncbi.nlm.nih.gov/PMC5073157
https://doaj.org/article/5f8b2a4f43b042858ed67a8accb8e0bb
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002152674
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Pediatric Endocrinology & Metabolism, 2016, 21(3), , pp.119-125
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKkRAXRHkGShUQN5Rl_YjjcKkoalWQlhMr9WY59risuk1KspXKv2cmya5YVBCnKA8n0efHfJ_tmWHsbYBI_pUh4w6qTHEIGfI4k0HwWgUdpCjJwXn2VZ_O1Zez_GyHrdMdjQB2t0o7yic1b5eTmx8_D7HDI3-dIP3O37srIJ9yrieCTyQOAuUddhctkyYxNhvpfj8yF6g4-uTWAoVCRqGtBj-av7xmy1b1If3RAtVtvI2N_rmp8jcrdfKQPRjpZfpxaA97bAfqR-zebFxAf8w-HN80XXMJXeq6FLlfOkzep01MyRGf9uq0HZ1dwgqbx3Lh03EJp3vC5ifH3z6dZmP6hMznuSwzF4toSoghjwBVQCMkpfAoQ2NUSIJMUMB9aSpeGAVl0DrQKqZCQjfFYjrKp2y3bmp4zlIHeqqiiQ7FlQrAXYGv5jq6WHLAsTZhfA2U9WNscUpxsbSoMQhcS-BaAtcKbiXqjjJh7zZlrobIGv98-ojw3zxJUbH7C017bsdOZvNoKuFUVLIiKZgbCLpwxnlfGZhWVcLeYO3ZC7_oy9PxvLEXrUXt8Jm0kBBcJuz1unItdjVaP3E1NNedRQARWGRYJmHPhsre_I8oCorciKWLrWaw9cPbd-rF9z6cNzJyyfPixX989yW7T6gMe9z22e6qvYZXSIpW1UE_mXDQt_dfZJ4Jdg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+as+the+source+of+biomarkers+of+metabolic+diseases&rft.jtitle=Annals+of+pediatric+endocrinology+%26+metabolism&rft.au=Lee%2C+Min-Jae&rft.au=Park%2C+Dong-Ho&rft.au=Kang%2C+Ju-Hee&rft.date=2016-09-01&rft.issn=2287-1012&rft.volume=21&rft.issue=3&rft.spage=119&rft_id=info:doi/10.6065%2Fapem.2016.21.3.119&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-1012&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-1012&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-1012&client=summon